XM
VTVT icon

XTX Markets’s vTv Therapeutics VTVT Stock Holding History

XTX Markets’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$27K Buy
+367
New +$28.1K 0.06% 191

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

XTX Markets's VTVT Position: Q4 2020 in Review

XTX Markets opened a new position in vTv Therapeutics (VTVT) in Q4 2020: 367 shares worth $27K. The stake represents 0.06% of the portfolio and ranks #191 among its holdings.

44 funds tracked by Wall St. Rank hold VTVT as of Q4 2020.

  • XTX Markets held 367 shares of vTv Therapeutics worth $27K as of Q4 2020.
  • vTv Therapeutics was a new XTX Markets position in Q4 2020.
  • vTv Therapeutics made up 0.06% of XTX Markets's portfolio in Q4 2020, its #191 holding.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.